Similar data were generated by our group: exposure to NVP-BKM120, a pan class PI3K inhibitor, on AML cells brought to mTOR deactivation, followed by a decrease in both glycolysis and oxidative phosphorylation [41]. Here, PIK3CD is linked to acute myeloid leukemia.